HEMOCHRON SIGNATURE ELITE WHOLE BLOOD MICROCOAGULATION SYSTEM

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a health professional report with the FDA on 2018-06-18 for HEMOCHRON SIGNATURE ELITE WHOLE BLOOD MICROCOAGULATION SYSTEM manufactured by Accriva Diagnostics.

Event Text Entries

[111448561] This mdr references accriva diagnostics' complaint number (b)(4) for the hemochron signature elite instrument, serial number (b)(4). Complaint number (b)(4) captures the child case for the lot number of the jact+ cuvette used during the procedure. (b)(4) actual device not evaluated. Process evaluation performed. Dhf review shows no history of service or repairs no results available since no evaluation performed. Conclusion not yet available - evaluation is in progress. Accriva diagnostics has requested all data required for form 3500a. Fields for which data were not obtainable or are not applicable are intentionally left blank.
Patient Sequence No: 1, Text Type: N, H10


[111448562] A healthcare professional reported discrepant act results with a hemochron signature elite and act+ whole blood microcoagulation system during an ablation procedure for an abnormal heart rhythm. The target act for this procedure was 350 to 400 seconds. The third act reading was 278 seconds, which was a lower than expected result. A repeat blood sample was drawn and tested on a different elite instrument. The act reading was 352 seconds, which was within the expected range. The repeat act result of 352 seconds was used for patient management. The procedure was completed successfully and no bleeding or other medical complications were reported. Both electronic and liquid quality controls passed prior to the procedure.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2250033-2018-00015
MDR Report Key7612282
Report SourceHEALTH PROFESSIONAL
Date Received2018-06-18
Date of Report2018-06-19
Date of Event2018-05-09
Date Mfgr Received2018-06-19
Device Manufacturer Date2014-03-28
Date Added to Maude2018-06-18
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationOTHER HEALTH CARE PROFESSIONAL
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactJON MCDERMED
Manufacturer Street6260 SEQUENCE DRIVE
Manufacturer CitySAN DIEGO CA 92121
Manufacturer CountryUS
Manufacturer Postal92121
Manufacturer Phone8582632490
Manufacturer G1ACCRIVA DIAGNOSTICS
Manufacturer Street6260 SEQUENCE DRIVE
Manufacturer CitySAN DIEGO CA 92121
Manufacturer CountryUS
Manufacturer Postal Code92121
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameHEMOCHRON SIGNATURE ELITE WHOLE BLOOD MICROCOAGULATION SYSTEM
Generic NameSYSTEM, MULTIPURPOSE FOR IN VITRO COAGULATION STUDIES
Product CodeJPA
Date Received2018-06-18
Returned To Mfg2018-05-22
Model NumberELITE
Catalog NumberELITE
OperatorHEALTH PROFESSIONAL
Device AvailabilityR
Device AgeDA
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerACCRIVA DIAGNOSTICS
Manufacturer Address6260 SEQUENCE DRIVE SAN DIEGO CA 92121 US 92121


Patients

Patient NumberTreatmentOutcomeDate
10 2018-06-18

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.